Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to -$94.3 million.

  • AVITA Medical's Other Operating Expenses rose 776.59% to -$94.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$53.1 million, marking a year-over-year increase of 869.15%. This contributed to the annual value of -$53.1 million for FY2025, which is 868.97% up from last year.
  • AVITA Medical's Other Operating Expenses amounted to -$94.3 million in Q4 2025, which was up 776.59% from $12.1 million recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Other Operating Expenses ranged from a high of $16.3 million in Q2 2024 and a low of -$102.3 million during Q4 2024
  • For the 5-year period, AVITA Medical's Other Operating Expenses averaged around -$5.5 million, with its median value being $627000.0 (2023).
  • The largest annual percentage gain for AVITA Medical's Other Operating Expenses in the last 5 years was 704339.62% (2024), contrasted with its biggest fall of 17345762.71% (2024).
  • Quarter analysis of 5 years shows AVITA Medical's Other Operating Expenses stood at $374000.0 in 2021, then surged by 174.33% to $1.0 million in 2022, then plummeted by 94.25% to $59000.0 in 2023, then tumbled by 173457.63% to -$102.3 million in 2024, then grew by 7.77% to -$94.3 million in 2025.
  • Its Other Operating Expenses was -$94.3 million in Q4 2025, compared to $12.1 million in Q3 2025 and $14.3 million in Q2 2025.